#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Penile cancer Sickle cell anaemia Choroidal dystrophy Thalassaemia Mixed-type liposarcoma Cerebral amyloid angiopathy Familial hypertriglyceridaemia Tourette's disorder Fatty acid oxidation disorder Chorioretinitis Dementia Neurodegenerative disorder Cervix carcinoma Arterial tortuosity syndrome Pituitary-dependent Cushing's syndrome More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Basic Information Paraneoplastic neurological syndrome – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics X-linked lymphoproliferative syndrome – Trials in Disease Pelizaeus-Merzbacher disease – Diagnostics Adrenocortical carcinoma – Life with Disease Ewing’s sarcoma metastatic – Basic Information Shprintzen-Goldberg syndrome – Treatment Soft tissue sarcoma – Trials in Disease Mast cell activation syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Naltrexone Hydrochloride Ceralasertib Bleomycin Sulfate Ph. Eur. Bidridistrogene Xeboparvovec THEOPHYLLINE ANHYDROUS Gskvx000000017033 Natalizumab Nicotinamide Rmc-6291 Nizaracianine Triflutate Mometasone Furoate Ph. Eur. ULTEVURSEN Citric Acid Monohydrate Isis 678354 Sodium Salt Triamcinolone Enmetazobactam Guanfacine Piromelatine Rosuvastatin Zinc Carbidopa More therapies…

    Learn about Your Condition

    Hyperchylomicronaemia Rhabdoid tumour of the kidney Synovial sarcoma Large cell lung cancer Gouty arthritis Herpes simplex meningitis Metastases to liver Stress Salivary gland cancer Gastric cancer stage IV HER2 negative breast cancer Breast cancer stage III Breast cancer Amnestic disorder Immune-mediated renal disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Nuernberg

Klinikum Nuernberg

Breslauer Strasse 201, Langwasser, Nürnberg, 90471, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Safety and Effectiveness of AZD0305 Alone and with Other Cancer Drugs for Adults with Relapsed or Refractory Multiple Myeloma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Azd0305
    • Dimethyl Fumarate
    • Elranatamab
    France Germany Spain

  • Study on the Effects of Immunoglobulin A, G, and M in Patients with Peritonitis and Sepsis After Infection Control

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritonitis
    • Sepsis
    • Septic shock
    Investigated Drugs:
    • Immunoglobulin A
    • Immunoglobulin G
    • Immunoglobulin M
    Austria Germany

  • Study to Compare Datopotamab Deruxtecan with Rilvegostomig or Alone Against Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Datopotamab Deruxtecan
    • Infliximab
    • Mycophenolate Mofetil
    Austria Belgium Germany Hungary Italy Poland +1

  • Study of Teclistamab and Lenalidomide as Maintenance Treatment for Newly Diagnosed Multiple Myeloma Patients After Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Lenalidomide
    • Teclistamab
    Austria Belgium Czechia Denmark France Germany +7

  • Study on the Effect of Acyclovir in ICU Patients with Pneumonia and Herpes Simplex Virus Type 1 Detected in Lung Fluid

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Herpes simplex
    Investigated Drugs:
    • Aciclovir
    Germany

  • Study on Reducing Immunosuppressive Drugs in Adults with Psoriatic Arthritis: Methotrexate Disodium, Abatacept, and Certolizumab Pegol

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Abatacept
    • Adalimumab
    • Apremilast
    Germany Italy

  • Study on Hilar Cholangiocarcinoma Treatment Using Porfimer Sodium and Foscan for Patients with Bile Duct Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cholangiocarcinoma
    Germany

  • Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Hormone receptor positive HER2 negative breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Fulvestrant
    Germany

  • Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acalabrutinib
    • Cyclophosphamide
    • Doxorubicin
    Germany Greece

  • Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin
    • Etoposide
    Austria Belgium Finland Germany Greece Hungary +2
Previous Page
1 2 3 4 5 6 … 11
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!